DOXGX | HQIVX | DOXGX / HQIVX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 2 years | 10 years | - |
Gain YTD | 16.358 | 14.623 | 112% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 116B | 5.31B | 2,183% |
Annual Yield % from dividends | 1.45 | 2.28 | 64% |
Returns for 1 year | 24.36 | 16.11 | 151% |
Returns for 3 years | N/A | 3.06 | - |
Returns for 5 years | N/A | 25.33 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FEQTX | 31.43 | 0.31 | +1.00% |
Fidelity Equity Dividend Income | |||
FWOAX | 17.52 | 0.14 | +0.81% |
Fidelity Advisor Women's Leadership A | |||
WFGGX | 26.38 | 0.18 | +0.69% |
First Trust WCM Focused Global Gr Inv | |||
SBHIX | 25.19 | 0.12 | +0.48% |
Saratoga Health & Biotechnology I | |||
GOFCX | 28.62 | 0.06 | +0.21% |
Pioneer Select Mid Cap Growth C |